Synutra Investors Ask Del. Justices To Remand $125M Suit
A controlling investor's early maneuvers in a $125 million buyout of baby formula maker Synutra Nutrition Inc. should have disqualified it for deferential "business judgment" protections in a dismissed court challenge,...To view the full article, register now.
Already a subscriber? Click here to view full article